Pediatr. praxi. 2011;12(5):336-338

Ventricular fibrillation as an initial clinical manifestation of myotonic dystrophy

MUDr.Marie Ryzí1, MUDr.Pavel Vít1, MUDr.Miroslava Burešová1, MUDr.Michal Ryzí2
1 Pediatrická klinika LF MU a FN Brno
2 Klinika dětské neurologie LF MU a FN Brno

Myotonic dystrophy type 1 (MD1) is an autosomal dominant disease affecting both striated and smooth muscle. Clinical symptomatology

of the disease includes not only muscular manifestations but also other symptoms resulting, in particular, from the involvement of the

heart, eyes, central nervous system or some endocrine glands.

A case report is presented of a boy who was diagnosed with asymptomatic MD1 at the age of ten years old. In the subsequent period,

he had not been under neurological observation and had never undergone cardiological evaluation. At the age of 17, he had collapsed

during sports and was found to have severe ventricular fibrillation. Subsequently, the boy underwent a comprehensive evaluation and

had an implantable cardioverter-defibrillator inserted as a prevention of further possible dysrhythmia. The paper aims to point out that

muscular diseases may involve some other, not uncommonly neglected accompanying symptoms.

Keywords: myotonic dystrophy type I, ventricular fibrillation, implantable cardioverter-defibrillator

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryzí M, Vít P, Burešová M, Ryzí M. Ventricular fibrillation as an initial clinical manifestation of myotonic dystrophy. Pediatr. praxi. 2011;12(5):336-338.
Download citation

References

  1. Muntau AC. Pediatrie. Praha: Grada Publishing 2009: 581.
  2. Ambler Z. Myotonická dystrofie. Neurol. praxi 2004; 3: 142-144.
  3. Ambler Z. Význam elektromyografie v neurologii. Neurologie 2003. Edice Trendy v medicíně. Praha Triton 382.
  4. Urbánek K. Neurodegenerativní onemocnění. Praha: Triton 2000: 223.
  5. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovascular research 1997; 33: 13-22. Go to original source... Go to PubMed...
  6. Lukl J, a kol. Srdeční arytmie. Aktuální problémy. Praha: Grada Publishing 1996: 228.
  7. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation 2002; 106: 2145-2161. Go to original source... Go to PubMed...
  8. Groh WJ, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008; 358: 2688-2693. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.